Akero Therapeutics Inc. (AKRO) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Akero Therapeutics Inc.

    NASDAQ: AKRO · Real-Time Price · USD
    44.72
    0.69 (1.57%)
    At close: Sep 05, 2025, 3:59 PM
    45.00
    0.63%
    Pre-market: Sep 08, 2025, 08:00 AM EDT

    Akero Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 340.24M 234.21M 249.77M 150.48M
    Short-Term Investments
    		 402.84M 315.8M 101.68M 37.77M
    Long-Term Investments
    		 54.75M 19.28M n/a n/a
    Other Long-Term Assets
    		 n/a n/a 108K 417K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 27.3M 9.95M n/a n/a
    Total Current Assets
    		 770.38M 559.96M 355.17M 193.58M
    Property-Plant & Equipment
    		 755K 1.03M 1.29M 1.55M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 55.51M 20.31M 1.4M 1.97M
    Total Assets
    		 825.89M 580.27M 356.57M 195.55M
    Account Payables
    		 9.03M 7.04M 7.97M 6.71M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a 205K
    Other Current Liabilities
    		 30.44M 1.3M 9.99M 17.46M
    Total Current Liabilities
    		 39.75M 19.13M 19.08M 25.13M
    Long-Term Debt
    		 35.3M 24.96M 9.54M 1.31M
    Other Long-Term Liabilities
    		 194K 54K 305K -1.31M
    Total Long-Term Liabilities
    		 36.02M 25.84M 10.93M 1.31M
    Total Liabilities
    		 75.77M 44.97M 30.01M 26.44M
    Total Debt
    		 36.12M 26.3M 10.95M 1.52M
    Common Stock
    		 7K 6K 5K 4K
    Retained Earnings
    		 -826.16M -574.1M -422.34M -310.3M
    Comprehensive Income
    		 948K 270K 37K -27K
    Shareholders Equity
    		 750.11M 535.31M 326.56M 169.11M
    Total Investments
    		 457.59M 335.09M 101.68M 37.77M

    Add to Watchlist